Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy

Hui Wang; Chenxi Huang

doi:10.12659/MSM.951769

29 December 2025 : Clinical Research

Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy

Hui Wang^{ABCDEFG 1*}, Chenxi Huang^{BDE 2}

DOI: 10.12659/MSM.951769

Med Sci Monit 2025; 31:e951769

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions Data Availability Statement References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 (A–D) Predictive value of neutrophil-lymphocyte ratio (NLR), soluble urokinase-type plasminogen activator receptor (suPAR), and their combination for postoperative biochemical recurrence in patients with prostate cancer.ROC curve analysis was used to evaluate the predictive value of NLR (A), suPAR (B), and their combination (C) for postoperative biochemical recurrence in patients with prostate cancer.

Back to the Article

Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy

Your Privacy